IDEXX LABORATORIES INC /DE·4

Feb 17, 7:30 PM ET

Lane Michael 4

4 · IDEXX LABORATORIES INC /DE · Filed Feb 17, 2026

Research Summary

AI-generated summary of this filing

Updated

IDEXX (IDXX) EVP Michael Lane Exercises/Converts Derivatives and Receives RSU Awards

What Happened

  • Michael Lane, Executive Vice President of IDEXX Laboratories (IDXX), received multiple restricted stock unit (RSU) awards on Feb 12, 2026 (totaling 8,405 RSU units) and on Feb 14, 2026 converted/exercised derivative awards into common shares. The filing shows conversions/exercises of 204, 220, 301 and 367 share units (1,092 shares total) and a withholding of 221 shares valued at $629.35 each (total $139,086) to satisfy tax/exercise-related obligations.
  • These were awards and conversions (codes A = award/grant; M = exercise/conversion; F = shares withheld to pay taxes/exercise price). The awards are derivative RSUs (no cash paid on grant/exercise, reported at $0.00 per share).

Key Details

  • Transaction dates: Grants/Awards on 2026-02-12; conversions/exercises and withholding on 2026-02-14. Filing date: 2026-02-17.
  • Award amounts (reported as derivative RSUs, acquired at $0): 5,361; 162; 1,262; and 1,620 shares (total 8,405 RSUs).
  • Conversions/exercises (M): 204, 220, 301, 367 shares (1,092 shares total). Matching “disposed” line items at $0 reflect net settlement/withholding rather than open-market sales.
  • Tax/exercise withholding (F): 221 shares withheld at $629.35 per share (closing price per footnote) = $139,086 withheld to cover tax/exercise liabilities.
  • Notable footnotes: several RSU grants are subject to deferred compensation treatment and multi-year vesting schedules (see notes F2, F4, F10–F13). Footnote F3 gives the $629.35 closing price used to value withheld shares. Footnote F1 notes small ESPP holdings and fractional-share rounding. Footnote F5 notes some shares held in spouse’s IRA (disclaimed).
  • Filing timeliness: no late-filing flag is indicated in the form.

Context

  • These transactions are primarily grant/award-related and conversions of derivative awards, not open-market purchases or voluntary sales. The withholding of 221 shares to cover taxes/exercise obligations is a routine administrative step (F-code) commonly used when RSUs vest or options are exercised.
  • For retail investors: awards and net-share settlements are routine compensation events and do not necessarily signal insider buying or selling intentions. Purchases would generally be more informative, but this filing documents compensation-related conversions and standard tax withholding.

Insider Transaction Report

Form 4
Period: 2026-02-12
Lane Michael
Executive Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-14+2047,356.944 total
  • Exercise/Conversion

    Common Stock

    2026-02-14+2207,576.944 total
  • Exercise/Conversion

    Common Stock

    2026-02-14+3017,877.944 total
  • Exercise/Conversion

    Common Stock

    [F2]
    2026-02-14+3678,244.944 total
  • Tax Payment

    Common Stock

    [F3][F4]
    2026-02-14$629.35/sh221$139,0868,023.944 total
  • Award

    Non-Qualified Stock Option (right-to-buy)

    [F6]
    2026-02-12+5,3615,361 total
    Exercise: $617.20Exp: 2036-02-11Common Stock (5,361 underlying)
  • Award

    Incentive Stock Option (right-to-buy)

    [F7]
    2026-02-12+162162 total
    Exercise: $617.20Exp: 2036-02-11Common Stock (162 underlying)
  • Award

    Restricted Stock Unit

    [F8]
    2026-02-12+1,2621,262 total
    Common Stock (1,262 underlying)
  • Award

    Restricted Stock Unit

    [F9]
    2026-02-12+1,6201,620 total
    Common Stock (1,620 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F10]
    2026-02-143671,101 total
    Common Stock (367 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F11]
    2026-02-142040 total
    Common Stock (204 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F12]
    2026-02-14220220 total
    Common Stock (220 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F13]
    2026-02-14301602 total
    Common Stock (301 underlying)
Holdings
  • Common Stock

    [F5]
    (indirect: By Spouse)
    592
Footnotes (13)
  • [F1]Includes a total of 21 shares purchased under the Issuer Employee Stock Purchase Plan ('ESPP') on September 30, 2025 and December 31, 2025. There are a total of 252.944 shares held in the ESPP which has been increased by 0.005 shares due to a rounding calculation of previously issued fractional shares.
  • [F10]Represents RSUs that were granted on February 14, 2025 and deferred in accordance with the Issuer's Deferred Compensation Plan and represents a contingent right to receive one share of Issuer common stock vesting in four annual installments, beginning February 14, 2026. Upon vesting, each such RSU will be recorded in an account under such Plan.
  • [F11]Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments, beginning February 14, 2023.
  • [F12]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
  • [F13]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.
  • [F2]Represents Restricted Stock Units ('RSU') that were granted on February 14, 2025, were deferred in accordance with the Issuer's Deferred Compensation Plan and have vested. Upon vesting, these RSUs were recorded in an account under such Plan and represents a contingent right to receive one share of Issuer common stock that is payable as soon as practicable after the reporting person's termination of employment with the Issuer.
  • [F3]Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026.
  • [F4]Includes 367 vested but deferred RSUs.
  • [F5]Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
  • [F6]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027.
  • [F7]Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030.
  • [F8]Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2027.
  • [F9]Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in three annual installments, beginning February 14, 2027.
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael Lane|2026-02-17

Documents

1 file
  • 4
    wk-form4_1771374647.xmlPrimary

    FORM 4